Trials / Terminated
TerminatedNCT03456271
A Prospective Cohort Study:Forecast Fracture Risk With a Serum Marker of Type 2 Diabetes in Guangzhou Community
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 99 (actual)
- Sponsor
- Zhujiang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to find out the biochemical markers which have independent predictive value of fragility fractures risk with Type 2 diabetes in Guangzhou community and evaluate bone strength better and increase the ability of recognizing fracture risk through following-up visits the bone metabolism index like esRAGE-to-pentosidine ratio of the petients with type 2 diabetes and osteoporosis,compared with the classical fracture risk assessment instrument.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | — |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2021-11-30
- Completion
- 2021-12-31
- First posted
- 2018-03-07
- Last updated
- 2022-03-21
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03456271. Inclusion in this directory is not an endorsement.